Clinical trials recruiting for Lobular Breast Carcinoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| 18F-fluorofuranylnorprogesterone | 1 |
| Adjuvant Radiotherapy | 1 |
| Endocrine therapy | 1 |
| FES | 1 |
| Neoadjuvant endocrine therapy | 1 |
| Palliative radiotherapy | 1 |
| Translational analysis | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| New Jersey | 2 |
| New York | 2 |
| California | 1 |
| Pennsylvania | 1 |
| Texas | 1 |
| Wisconsin | 1 |
Top cities
Self-screener
Recruiting trials
- 18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer
- A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
- Biomarkers to Detect Endocrine Therapy Resistance
- Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
- Negative/Low Hormone Receptor And/or HER2 POsitive Lobular Invasive Breast Carcinoma - A Real-World International Cohort Study
Related conditions
Trials recruiting for Lobular Breast Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Lobular Breast Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.